Status:

RECRUITING

Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

Lead Sponsor:

Sidney Kimmel Cancer Center at Thomas Jefferson University

Conditions:

Glioblastoma

WHO Grade II Glioma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This phase II trial studies how well intensity-modulated stereotactic radiation therapy works in treating patients with grade II-IV glioma. Stereotactic radiosurgery is a specialized radiation therapy...

Detailed Description

PRIMARY OBJECTIVES: I. To determine the effect of intensity-modulated (IM)-stereotactic radiotherapy (SRT) on the incidence of wound infection (requiring oral/intravenous \[IV\] antibiotics or surger...

Eligibility Criteria

Inclusion

  • Patients must have histologically confirmed low or high grade glioma (grade II-IV)
  • Karnofsky performance status (KPS) \>= 60
  • Patients must have recovered from the effects of surgery; there must be a minimum of 21 days from the day of surgery to the day of protocol treatment
  • Estimated survival \>= 3 months
  • Labs considered acceptable per standard of care
  • Patient must sign a study specific informed consent form
  • Radiation treatment must begin \>= 3 weeks and =\< 8 weeks after surgery

Exclusion

  • Prior history of scalp radiation or intolerance to standard course of radiation treatment
  • Co-morbidities that would influence wound healing including diabetes (insulin dependent) or smoking (current ongoing use)
  • Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception
  • Karnofsky performance status (KPS) \< 60
  • Patient can't have magnetic resonance imaging (MRI) scan
  • Active collagen vascular disease

Key Trial Info

Start Date :

July 17 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

125 Patients enrolled

Trial Details

Trial ID

NCT03251027

Start Date

July 17 2017

End Date

December 31 2025

Last Update

May 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107